home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

TBK1 Is Doubly Important

 
  February, 7 2008 10:07
your information resource in human molecular genetics
 
     

To develop optimal vaccines for clinical applications it is vital to understand the mechanisms of their actions, and research in Nature demonstrates how DNA vaccines may induce adaptive immune responses.

DNA vaccines induce adaptive immune responses, mainly through induction of type I interferons. Ken Ishii and colleagues use mice to show that this occurs by a mechanism that is independent of the activation of nucleic-acid-binding Toll-like receptors. Instead, some T-cell responses require activation of the TANK-binding kinase 1 (TBK1)-mediated innate immune signalling pathway in haematopoietic cells. In non-haematopoietic cells, TBK1 is critical for the activation of CD8 T cells. Therefore, in two distinct cellular mechanisms, TBK1 is a key player in DNA-vaccine-induced immunity.

CONTACT

Ken Ishii (Osaka University, Japan)
E-mail: kenishii@biken.osaka-u.ac.jp

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.